Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

Carillon Mitral Contour System® Case Experience

Presenter: Amar Krishnaswamy

June 08, 2023

Presentation TVT 2023

The Basis of Transcatheter Annular Restoration (TAR) for Ventricular Remodeling: A closer look at the mechanism of action

Presenter: Richard Cheng

June 08, 2023

Presentation TVT 2023

The European Experience – What we have learned

Presenter: Murat Yildiz

June 08, 2023

Presentation TVT 2023

Carillon Mitral Contour System® and the EMPOWER Trial – Overview and its Importance in interventional heart failure

Presenter: Rahul Sharma

June 08, 2023

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Todd Neale

July 22, 2021

News Conference News TVT 2021

Timing of Mitral Surgery After Failed TEER Influences Outcomes

Todd Neale

July 21, 2021

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

Advertisement

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Carillon Mitral Contour System® Case Experience

The Basis of Transcatheter Annular Restoration (TAR) for Ventricular Remodeling: A closer look at the mechanism of action

The European Experience – What we have learned

Carillon Mitral Contour System® and the EMPOWER Trial – Overview and its Importance in interventional heart failure

More Support for Single Antiplatelet Therapy After TAVI

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

Timing of Mitral Surgery After Failed TEER Influences Outcomes

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content